[
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Results from animal studies demonstrate the promise of NPs for improving outcomes in patients suffering from brain tumors, and continued investigation is necessary to translate these findings into routine practice.Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.Abbreviations\n\n\nAMT\nAdsorptive-mediated transcytosis\n\n\nBBB\nBlood-brain barrier\n\n\nBBTB\nBlood-brain tumor barrier\n\n\nCNS\nCentral nervous system\n\n\nFUS\nFocused ultrasound\n\n\nGNP\nGold nanoparticle\n\n\nLDL\nLow-density lipoprotein\n\n\nMRI\nMagnetic Resonance Imaging\n\n\nNP\nNanoparticle\n\n\nPBCA\nPoly(butyl cyanoacrylate)\n\n\nPEG\nPolyethylene glycol\n\n\nPLA\nPoly(lactic acid)\n\n\nQD\nQuantum dots\n\n\nRES\nReticuloendothelial system\n\n\nRMT\nReceptor-mediated transport\n\n\nSLN\nSolid lipid nanoparticle\n\n\nTAT\nTransactivator of transcription\n\n\nTf\nTransferrin receptor\n\n\nTfR\nTransferring receptor\n\n\nTJ\nTight junction\n\n\nOpen in a new tabAuthor Contributions\nConceptualization, B.M.T.; Methodology, A.M.H. and S.A.; software, A.M.H.; investigation, A.M.H.; resources, B.M.T.; data curation, A.M.H.; writing—original draft preparation, A.M.H.; writing—review and editing, S.A. and B.M.T.; visualization, S.A. and B.M.T.; supervision, B.M.T.; project administration, B.M.T.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Once NPs arrive at the BBB, they can cross using several strategies, including passive diffusion, carrier transport, and adsorptive- and receptor-mediated transcytosis (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Their structure consists of a core atom or group of atoms from which building blocks repeatedly extend, resembling a tree (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Chemotherapeutics can be loaded to the TAT-GNP conjugate, such as doxorubicin, which displays 3–14x greater cytotoxicity and improves survival time in mice compared to doxorubicin treatment alone (Figure 3) [152].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Acknowledgments\nFigure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 1, Figure 2 and Figure 3 created with BioRender.com, accessed on 13 March 2022.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  }
]